相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence, incidence and survival of heart failure: a systematic review
Sophia Emmons-Bell et al.
HEART (2022)
Rare and Common Variants in KIF15 Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis
David Zhang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017
Nicola Luigi Bragazzi et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy
Yuxuan Luo et al.
CIRCULATION (2021)
Cardiac fibrosis
Nikolaos G. Frangogiannis
CARDIOVASCULAR RESEARCH (2021)
Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology
Pietro Ameri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CTRP15 derived from cardiac myocytes attenuates TGFβ1-induced fibrotic response in cardiac fibroblasts
Qian Zhao et al.
CARDIOVASCULAR DRUGS AND THERAPY (2020)
KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis
Jinqiu Tao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
High-Resolution Transcriptomic Profiling of the Heart During Chronic Stress Reveals Cellular Drivers of Cardiac Fibrosis and Hypertrophy
Micheal A. McLellan et al.
CIRCULATION (2020)
KIF15 contributes to cell proliferation and migration in breast cancer
Xiaokang Gao et al.
HUMAN CELL (2020)
Downregulation of FOXO6 alleviates hypoxia-induced apoptosis and oxidative stress in cardiomyocytes by enhancing Nrf2 activation via upregulation of SIRT6
Aiping Jin et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2020)
Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway
Jie Liu et al.
CIRCULATION (2019)
Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure
Kevin J. Morine et al.
CIRCULATION (2018)
Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis
Shuin Park et al.
CIRCULATION (2018)
MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress
Jie Yuan et al.
THERANOSTICS (2018)
Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies
Mengen Zhai et al.
JOURNAL OF PINEAL RESEARCH (2017)
Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer
Jia-Hong Wang et al.
ONCOTARGET (2017)
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy
Xiaoqiang Tang et al.
CIRCULATION (2017)
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy
Baktybek Kojonazarov et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium
Atsushi Tachibana et al.
CIRCULATION RESEARCH (2017)
Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling
Yulin Li et al.
CIRCULATION (2017)
FOXOs in the impaired heart: New therapeutic targets for cardiac diseases
Zhenlong Xin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Cardiac Fibrosis The Fibroblast Awakens
Joshua G. Travers et al.
CIRCULATION RESEARCH (2016)
Transcriptional control of cardiac fibroblast plasticity
Janet K. Lighthouse et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Physiological and pathological cardiac hypertrophy
Ippei Shimizu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Mechanotransduction in Cardiac Hypertrophy and Failure
Robert C. Lyon et al.
CIRCULATION RESEARCH (2015)
FoxO6 Integrates Insulin Signaling With MTP for Regulating VLDL Production in the Liver
Dae Hyun Kim et al.
ENDOCRINOLOGY (2014)
Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes
Shali Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
FOXO transcription factors: key regulators of cellular quality control
Ashley E. Webb et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
X. Li et al.
CELL DEATH & DISEASE (2014)
Regulation of fetal gene expression in heart failure
Ellen Dirkx et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
FoxO6 and PGC-1α form a regulatory loop in myogenic cells
Shih Ying Chung et al.
BIOSCIENCE REPORTS (2013)
Transcription Factor Foxo3a Prevents Apoptosis by Regulating Calcium through the Apoptosis Repressor with Caspase Recruitment Domain
Daoyuan Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver
Dae Hyun Kim et al.
DIABETES (2011)
Communication Signals Between Cardiac Fibroblasts and Cardiac Myocytes
Filomena G. Ottaviano et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
The FoxO Family in Cardiac Function and Dysfunction
Sarah M. Ronnebaum et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating Catalase
Wei-Qi Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
分享论文
